JJ PHARMA CONSULT ApS: Financial statements 2015
CVR: 33257635
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -17,398 and a net result of DKK 582,439 compared with DKK 920,163 the year before. Equity in the 2015 report amounted to DKK 1,416,253. The solvency ratio was 98.9%.
- Gross Profit
- DKK -17,398
- Profit/Loss
- DKK 582,439
- Equity
- DKK 1,416,253
- Total Assets
- DKK 1,432,560
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -17 t. | 582 t. | 1.4 mio. | - |
| 2014 | - | -23 t. | 920 t. | 934 t. | - |
| 2013 | - | -9 t. | 95 t. | 183 t. | - |
| 2012 | - | -6 t. | 22 t. | 89 t. | - |
Official annual report
How creditworthy is JJ PHARMA CONSULT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
JJ PHARMA CONSULT ApS has published its annual report for 2014. Gross profit came to DKK -22,985, and the net result was DKK 920,163.
About JJ PHARMA CONSULT ApS
JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity in the 2025 report amounted to DKK 16,917,153.